Gilead sues Teva over approval application for generic Truvada

Alaric DeArment

12/16/2008

NEW YORK Gilead Sciences has filed a lawsuit against Israeli generic drug maker Teva Pharmaceutical Industries and a subsidiary.

Gilead, which filed the suit Friday in a United States District Court in New York, alleged that Teva committed patent infringement when it filed an approval application with the Food and Drug Administration for a generic version of Truvada (emtricitabine), a drug for treating HIV.

Gilead has a license to manufacture and sell the drug from Emory University in Atlanta.

CVS Weight Management program improves health outcomes, lowers costs

As of Feb. 1, the CVS Weight Management program is available to more than 3.5 million CVS Caremark plan members.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.

Meijer to open 3 new Northeast Ohio Supercenters

The new stores in Austintown, Medina and Richmond Heights increase the retailer's store count to 58 in Ohio.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Kiss Products unveils ‘Wicked’-inspired nail, lash collection

The collection includes lashes and nails from Kiss Nails, imPress Nails, Falscara and imPress Faslsies lines.